NCT07063212 2026-02-19A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)Memorial Sloan Kettering Cancer CenterPhase 2 Recruiting40 enrolled